Background and Objective: Lumbar disc herniation (LDH) and lumbar spinal stenosis (LSS) are the most common diagnoses of low back and leg pain symptoms. The Japanese Orthopedic Association Back Pain Evaluation Questionnaire (JOABPEQ) is a measure of health related quality of life in these patients. This study aimed to cross-culturally translate and validate the JOABPEQ in Iran.
Methods: This was a prospective clinical validation trial. The translation and cross-cultural adaptation of the original questionnaire were performed in accordance with the published guidelines. A total of 103 patients with LDH or LSS were asked to respond to the questionnaire at two time points: pre- and post-operation (pre- and post-operative assessments) and were followed up for 6 months. To evaluate the reliability the internal consistency was assessed using the Cronbach's alpha coefficient and validity was assessed using the convergent validity. Responsiveness to the clinical change also was assessed comparing patients’ pre- and postoperative scores.
Results: The Cronbach’s alpha coefficients for the JOABPEQ at preoperative and postoperative assessments ranged from 0.71 to 0.81 indicating a good internal consistency for the questionnaire. Furthermore, the correlation of each item with its hypothesized subscale of the JOABPEQ showed satisfactory results suggesting that the items had a substantial association with the subscale representing the concept. Further analysis also indicated that the questionnaire was responsive to change (P < 0.0001).
Conclusions: In conclusion, the Iranian version of JOABPEQ performed well and the findings suggest that it is a reliable and valid measure of back pain evaluation among LDH and LCS patients.
Copyright. In accordance with Bethesda Statement on Open Access Publishing (released June 20, 2003, available from: http://www.earlham.edu/~peters/fos/bethesda.htm), all works published in JIVR are open access and are immediately available to anyone on the website of the journal without cost. JIVR is an open-access journal distributed under the terms of the Creative Commons Attribution 3.0 License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.